The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.

Atherly, A J

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers. [electronic resource] - British journal of cancer Mar 2012 - 1100-6 p. digital

Publication Type: Journal Article

1532-1827

10.1038/bjc.2012.60 doi


Anaplastic Lymphoma Kinase
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
Cost-Benefit Analysis
Crizotinib
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Models, Biological
Molecular Targeted Therapy--economics
Precision Medicine--economics
Pyrazoles--pharmacology
Pyridines--pharmacology
Quality of Life
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors